15-38322338-C-T
Variant summary
Our verdict is Likely pathogenic. The variant received 9 ACMG points: 9P and 0B. PM2PM5PP3_StrongPP5
The NM_152594.3(SPRED1):c.305C>T(p.Thr102Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000124 in 1,613,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T102R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_152594.3 missense
Scores
Clinical Significance
Conservation
Publications
- Legius syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics, Genomics England PanelApp, ClinGen, PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 9 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_152594.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPRED1 | NM_152594.3 | MANE Select | c.305C>T | p.Thr102Met | missense | Exon 3 of 7 | NP_689807.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPRED1 | ENST00000299084.9 | TSL:1 MANE Select | c.305C>T | p.Thr102Met | missense | Exon 3 of 7 | ENSP00000299084.4 | ||
| SPRED1 | ENST00000561317.1 | TSL:4 | c.242C>T | p.Thr81Met | missense | Exon 4 of 6 | ENSP00000453680.1 | ||
| SPRED1 | ENST00000561205.1 | TSL:5 | n.643C>T | non_coding_transcript_exon | Exon 3 of 5 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152144Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251116 AF XY: 0.00000737 show subpopulations
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461616Hom.: 0 Cov.: 33 AF XY: 0.00000138 AC XY: 1AN XY: 727108 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74324 show subpopulations
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:1
Legius syndrome Uncertain:1
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 102 of the SPRED1 protein (p.Thr102Met). This variant is present in population databases (rs754706111, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of Legius syndrome (PMID: 26635368). ClinVar contains an entry for this variant (Variation ID: 1407466). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SPRED1 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SPRED1 function (PMID: 26635368). This variant disrupts the p.Thr102 amino acid residue in SPRED1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19920235, 21089071, 22751498, 31401120; internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at